Meiyu Geng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Endoplasmic Reticulum Stress

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Signal transduction and targeted therapy

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Xiameng Gai, Yingluo Liu, Xiaojing Lan, Luoyi Chen, Tao Yuan, Jun Xu, Yize Li, Ying Zheng, Yiyang Yan, Liya Yang, Yixian Fu, Shuai Tang, Siyuwei Cao, Xiaoyang Dai, Hong Zhu, Meiyu Geng, Jian Ding, Congying Pu, Min Huang
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer. Cancer research 84 (12) (2024)
Hangtian Yue, Hui Xu, Lanping Ma, Xiyuan Li, Biyu Yang, Xiyuan Wang, Qingzhong Zeng, Han Li, Deqiang Zhang, Meiyu Geng, Tao Meng, Zuoquan Xie
A DXd/TLR7-agonist dual-conjugate anti-HER2 ADC exerts robust anti-tumor activity through tumor cell killing and immune activation. Molecular cancer therapeutics (2024)
Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Xiameng Gai, Yingluo Liu, Xiaojing Lan, Luoyi Chen, Tao Yuan, Jun Xu, Yize Li, Ying Zheng, Yiyang Yan, Liya Yang, Yixian Fu, Shuai Tang, Siyuwei Cao, Xiaoyang Dai, Hong Zhu, Meiyu Geng, Jian Ding, Congying Pu, Min Huang
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer. Cancer research (2024)
Zuoquan Xie, Zhen Wang, Fengying Fan, Jinpei Zhou, Zhaoxue Hu, Qingxia Wang, Xiyuan Wang, Qingzhong Zeng, Yan Zhang, Jiaxuan Qiu, Xiaoqian Zhou, Hui Xu, Hudagula Bai, Zhengsheng Zhan, Jian Ding, Huibin Zhang, Wenhu Duan, Xuekui Yu, Meiyu Geng
Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation. Cell discovery 8 (1) (2022)
Zuoquan Xie, Zhen Wang, Fengying Fan, Jinpei Zhou, Zhaoxue Hu, Qingxia Wang, Xiyuan Wang, Qingzhong Zeng, Yan Zhang, Jiaxuan Qiu, Xiaoqian Zhou, Hui Xu, Hudagula Bai, Zhengsheng Zhan, Jian Ding, Huibin Zhang, Wenhu Duan, Xuekui Yu, Meiyu Geng
Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation. Cell discovery 8 (1) (2022)